Sage

Dosage for Sage allergenic extracts is highly individualized and depends entirely on the method of administration and the patient's level of sensitivity. There is no 'standard' dose for non-standardized extracts.

• Skin Prick Testing (SPT): A single drop of the extract (typically at a concentration of 1:10 or 1:20 weight/volume) is applied to the volar surface of the forearm or the back. A sterile lancet is then used to prick the skin through the drop. A positive control (histamine) and a negative control (saline/glycerin) are always used simultaneously for comparison.
• Intradermal Testing: If the SPT is negative, a healthcare provider may inject 0.02 mL to 0.05 mL of a 1:100 or 1:1000 dilution of the extract into the intradermal layer of the skin.
• Immunotherapy: Dosing begins with a 'build-up phase' using extremely dilute solutions (e.g., 0.05 mL of a 1:100,000 dilution). Doses are increased weekly or bi-weekly until a 'maintenance dose' is reached, which is typically the highest dose the patient can tolerate without a systemic reaction.

Sage allergenic extracts are used in children for allergy diagnosis. The procedure for skin prick testing is identical to that in adults. However, clinicians must exercise extreme caution in very young children (under age 5) due to the higher relative risk of systemic reactions and the difficulty in interpreting skin results on smaller surface areas. Immunotherapy in children is generally reserved for those over the age of 5 who can communicate symptoms of a systemic reaction.

Renal Impairment

No specific dose adjustments are required for renal impairment, as the systemic load of the allergenic protein is minimal during diagnostic testing. However, patients with end-stage renal disease may have altered skin reactivity (uremic pruritus), which can make skin test interpretation difficult.

Hepatic Impairment

No dosage adjustments are established for patients with liver disease. The metabolism of these proteins is not dependent on hepatic CYP450 pathways.

Elderly Patients

Elderly patients may exhibit reduced skin reactivity due to age-related changes in skin physiology (atrophy of mast cells). This may lead to false-negative results. Healthcare providers may need to use higher concentrations or rely more heavily on in vitro (blood) testing.

Sage extracts are never self-administered by the patient for diagnostic purposes. They must be administered in a clinical setting (allergy clinic or hospital) equipped with emergency resuscitation equipment.

1. 1Preparation: The skin site (usually the forearm) is cleaned with alcohol.
2. 2Application: Drops are placed at least 2-3 cm apart to prevent overlapping of reactions.
3. 3Observation: The patient must remain in the clinic for at least 30 minutes after the test to monitor for systemic reactions (anaphylaxis).
4. 4Storage: Vials must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Freezing can denature the allergenic proteins, rendering the extract ineffective.

In the context of diagnostic testing, a missed appointment simply means the test must be rescheduled. For patients on immunotherapy, a missed dose can be critical. If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated to maintain safety. If several weeks are missed, the build-up may need to be restarted from a lower concentration.

An 'overdose' in allergenic extracts refers to the administration of a concentration that exceeds the patient's tolerance level, leading to a systemic allergic reaction.

• Signs: Hives (urticaria), swelling of the throat (angioedema), wheezing, shortness of breath, rapid heart rate, or a drop in blood pressure (shock).
• Emergency Measures: Immediate administration of Epinephrine (EpiPen) is the first-line treatment. Other measures include antihistamines, corticosteroids, and IV fluids. If you experience any of these symptoms after a test, seek emergency help immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to use these extracts outside of a supervised medical environment.

Because the goal of Sage allergenic extract testing is to provoke a local immune response, certain 'side effects' are actually expected clinical markers of the test's success.

• Local Wheal and Flare: This is the most common result. It feels like a mosquito bite—a raised, itchy bump (wheal) surrounded by a red area (flare). It typically peaks at 15-20 minutes and subsides within 1-2 hours.
• Pruritus (Itching): Intense itching at the site of the test is very common. Patients are advised not to scratch, as this can cause skin trauma and interfere with the reading.
• Local Erythema: Redness that may spread slightly beyond the test site.

• Delayed Local Reaction: Some patients experience swelling and redness at the test site 6 to 24 hours after the extract was applied. This is usually a Type IV (cell-mediated) hypersensitivity response and should be reported to the doctor.
• Large Local Reactions: Swelling that exceeds 10 cm in diameter. This may be painful or warm to the touch and can last for several days.
• Fatigue: Some patients report feeling unusually tired for a few hours following a multi-allergen skin test panel.

• Lymphangitis: Inflammation of the lymph vessels leading away from the injection site, appearing as red streaks.
• Vasovagal Reaction: Fainting or lightheadedness caused by the stress or pain of the needle prick, rather than the extract itself.
• Systemic Hives: Hives appearing on parts of the body far away from the test site.

> Warning: Stop the procedure and call for emergency medical help immediately if you experience any of the following symptoms of anaphylaxis.

• Respiratory Distress: Difficulty breathing, wheezing, or a high-pitched sound when breathing (stridor).
• Upper Airway Obstruction: A feeling of 'tightness' in the throat, difficulty swallowing, or a hoarse voice.
• Cardiovascular Collapse: Sudden dizziness, confusion, rapid or weak pulse, or loss of consciousness.
• Gastrointestinal Distress: Sudden, severe abdominal cramping, vomiting, or diarrhea occurring immediately after the test.

For diagnostic testing, there are no known long-term side effects. For patients receiving long-term immunotherapy with Sage extracts, there is a theoretical risk of developing 'serum sickness' (a delayed immune complex reaction), though this is extremely rare with modern extracts. Prolonged use of high-dose extracts in immunotherapy can occasionally lead to the development of new sensitivities, though the goal is the opposite (desensitization).

While non-standardized extracts like Sage may not always carry a specific 'Black Box' on the vial, the FDA requires a General Boxed Warning for the entire class of allergenic extracts.

FDA WARNING: RISK OF SEVERE ALLERGIC REACTIONS

• Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis.
• Extracts must only be administered by healthcare providers prepared to manage such reactions.
• Patients with unstable or severe asthma are at increased risk for fatal reactions.
• Patients taking beta-blockers may be resistant to the effects of epinephrine used to treat a reaction.

Report any unusual symptoms to your healthcare provider immediately. Even a small local reaction can sometimes be a precursor to a more significant systemic event in future exposures.

Sage allergenic extracts are biological products that carry inherent risks of immunological provocation. Every patient undergoing testing or treatment must be aware that the goal of the product is to stimulate the immune system, which can, in rare cases, lead to an overreaction. It is mandatory that these extracts are used only in facilities where emergency medications (epinephrine, oxygen, IV fluids) and trained personnel are immediately available.

No specific FDA black box warning exists solely for 'Sage' as an individual ingredient; however, it falls under the mandatory Boxed Warning for all Allergenic Extracts. This warning emphasizes that these products can cause anaphylaxis and should only be administered in a medical setting. It also notes that patients with severe or poorly controlled asthma should not undergo testing until their condition is stabilized.

• Anaphylaxis Risk: This is the most significant concern. Risk factors include a history of severe allergic reactions, high degree of sensitivity on previous tests, and the use of high-concentration extracts.
• Asthma Exacerbation: Patients with active asthma symptoms or reduced FEV1 (forced expiratory volume) are at a much higher risk of a systemic reaction. Testing should be postponed if the patient is experiencing an asthma flare.
• Beta-Blocker Use: Patients taking beta-blockers (e.g., metoprolol, propranolol) for high blood pressure or heart conditions may not respond to epinephrine if an allergic reaction occurs. This makes a standard reaction potentially fatal.
• Skin Conditions: Patients with severe eczema, dermatitis, or dermatographism (where skin wheals easily from simple touch) may produce false-positive results, making the test uninterpretable.

• Pre-Test Assessment: A physical exam and history are required to ensure the patient is not currently experiencing an allergic flare or illness.
• Post-Test Observation: A minimum 30-minute wait time in the clinic is mandatory after any administration of Sage extract.
• Peak Flow Monitoring: For asthmatic patients, a peak flow meter may be used before and after testing to ensure lung function remains stable.

Sage extracts do not typically cause drowsiness or cognitive impairment. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until cleared by a physician. Some patients may feel faint (vasovagal response) after the needle sticks and should wait until they feel stable before leaving.

Alcohol should be avoided for at least 24 hours before and after allergy testing. Alcohol can increase peripheral blood flow (vasodilation), which may enhance the skin's reactivity or speed up the systemic absorption of the allergen, potentially increasing the risk of a severe reaction.

If a patient experiences a systemic reaction to Sage extract, the testing or immunotherapy must be immediately discontinued. Future use of the extract must be carefully re-evaluated using much lower concentrations.

> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Sage testing.

• Beta-Blockers (Non-selective and Selective): Drugs like Propranolol, Atenolol, and Metoprolol are contraindicated during allergy testing. The clinical consequence is that beta-blockers inhibit the action of epinephrine, which is the only effective treatment for anaphylaxis. If a patient on a beta-blocker has a severe reaction to Sage extract, the standard emergency treatment may fail.

• ACE Inhibitors: Drugs like Lisinopril or Enalapril may increase the severity of an allergic reaction or interfere with the body's compensatory mechanisms during anaphylaxis.
• MAO Inhibitors (MAOIs): Used for depression (e.g., Phenelzine), these can potentiate the effects of epinephrine, leading to a dangerous spike in blood pressure if an allergic reaction is treated.
• Tricyclic Antidepressants (TCAs): Similar to MAOIs, TCAs (e.g., Amitriptyline) can increase the cardiovascular effects of epinephrine.

• Antihistamines: Medications like Cetirizine (Zyrtec), Loratadine (Claritin), and Diphenhydramine (Benadryl) must be stopped 3 to 7 days before testing. These drugs block the H1 receptors in the skin, which will prevent the 'wheal and flare' from appearing, leading to a false-negative result.
• H2 Blockers: Drugs like Famotidine (Pepcid) can also slightly reduce skin reactivity and should be discontinued 48 hours before testing.
• Topical Corticosteroids: Applying steroid creams to the test site will suppress the local immune response and invalidate the test.

• Cross-Reactive Foods: Sage belongs to the Lamiaceae (mint) family. Patients allergic to Sage may show cross-reactivity with other herbs like oregano, basil, thyme, or mint. Consuming these foods shortly before a test might increase the baseline sensitivity of the immune system.
• Caffeine: High doses of caffeine can cause tremors or tachycardia, which might be confused with the early signs of an allergic reaction.

• St. John's Wort: May affect the metabolism of other medications used during an emergency.
• Thujone-containing Supplements: Since Sage naturally contains thujone (a neurotoxin), taking high-dose Sage supplements while undergoing allergenic testing might increase the risk of neurotoxic side effects like dizziness or, in extreme cases, seizures.

Sage extracts are used for testing and do not typically interfere with other blood labs. However, recent administration of Sage extract might temporarily elevate total serum IgE levels or peripheral eosinophil counts.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or allergies.

Sage allergenic extracts must NEVER be used in the following circumstances:

1. 1History of Severe Anaphylaxis to Sage: If a patient has previously had a life-threatening reaction to Sage or its constituents, further skin testing is too dangerous and in vitro (blood) testing should be used instead.
2. 2Uncontrolled Asthma: Patients with an FEV1 consistently below 70% of predicted value or those experiencing an acute asthma exacerbation are at an unacceptably high risk of a fatal respiratory reaction.
3. 3Recent Myocardial Infarction (Heart Attack): Within the last 3-6 months. The stress of a potential systemic reaction and the subsequent need for epinephrine could cause further cardiac damage or arrhythmias.

Conditions requiring a careful risk-benefit analysis include:

• Pregnancy: While not directly teratogenic, the risk of maternal anaphylaxis causing fetal hypoxia (lack of oxygen) is a major concern. Testing is usually postponed until postpartum.
• Beta-Blocker Therapy: If the medication cannot be safely stopped, the clinician must weigh the diagnostic necessity against the risk of epinephrine resistance.
• Severe Atopic Dermatitis: If there is no clear area of healthy skin to test, the results will be unreliable.
• Autoimmune Disorders: Patients with active systemic lupus erythematosus (SLE) or other autoimmune conditions may have unpredictable immune responses to allergenic provocation.

Patients with known allergies to other members of the Lamiaceae family (Mint, Rosemary, Lavender, Oregano) may exhibit cross-sensitivity to Sage. This is due to shared protein structures (homologous allergens). Clinicians should be prepared for a potentially stronger reaction in these individuals.

> Important: Your healthcare provider will evaluate your complete medical history, including heart and lung health, before prescribing or administering Sage extracts.

Sage allergenic extracts are generally classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. The primary risk is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis) in the mother. Anaphylaxis causes a sudden drop in blood pressure and respiratory distress, which can lead to placental insufficiency and fetal hypoxia. Consequently, skin testing and the initiation of immunotherapy are typically avoided during pregnancy. If a woman is already on a stable maintenance dose of immunotherapy, it may be continued with caution, but doses are never increased during pregnancy.

It is not known whether the allergenic proteins from Sage extract are excreted in human milk. However, since these are large proteins that are rapidly metabolized, it is unlikely they would reach the infant in significant amounts. A specific concern with Sage is its historical use as an 'antigalactagogue' (a substance that suppresses milk production). High doses of Sage herb are known to reduce breast milk supply; whether the small amounts in an allergenic extract have this effect is unknown, but nursing mothers should be monitored for a decrease in milk volume.

Sage extracts are approved for use in children for diagnostic purposes. There is no specific age limit, but testing infants under 6 months is rarely productive as their immune systems have not had sufficient time to become sensitized. In children, the risk of a systemic reaction is similar to adults, but the management is more complex due to weight-based dosing of epinephrine. Healthcare providers must use pediatric-specific emergency protocols.

Clinical studies of allergenic extracts often do not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. In general, elderly patients have thinner skin and fewer mast cells, which can lead to smaller wheal sizes. Furthermore, the higher prevalence of cardiovascular disease in the elderly increases the risk of complications if a systemic reaction occurs or if epinephrine must be administered.

Patients with chronic kidney disease (CKD) may have altered skin reactivity. Uremia (buildup of toxins in the blood) is known to suppress the immediate skin test response. While no dose adjustment is needed, a negative skin test in a patient with severe renal impairment should be interpreted with caution and confirmed with a blood test (Specific IgE).

No specific studies have been conducted in patients with hepatic impairment. Since the proteins are degraded by general proteases and not specifically by the liver, no dosage adjustments are typically required. However, patients with severe liver disease may have coagulopathies (bleeding disorders) that could increase the risk of bruising at the test site.

> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, nursing, or have underlying organ dysfunction.

Sage (Salvia officinalis) allergenic extract functions as a diagnostic antigen. The molecular mechanism involves the binding of specific Sage allergens—primarily proteins in the 10-70 kDa range—to IgE antibodies sensitized on the surface of cutaneous mast cells. This binding causes the aggregation of FcεRI receptors, leading to an influx of calcium ions and the subsequent exocytosis of pre-formed mediators like histamine. Histamine then acts on H1 receptors in the local vasculature to cause vasodilation (the flare) and increased capillary permeability (the wheal). In immunotherapy, the mechanism involves the induction of 'blocking antibodies' (IgG4) and the modulation of T-cell responses from Th2 to Th1/Treg profiles.

• Onset of Action: For skin testing, the local reaction begins within 5 minutes and peaks at 15-20 minutes.
• Duration of Effect: The visible wheal and flare typically resolve within 1 to 2 hours, though the immunological priming of the site can last for days.
• Dose-Response: There is a direct correlation between the concentration of the extract and the size of the wheal, up to a saturation point. Highly sensitive individuals will show a large response even at very low concentrations.

| Parameter | Value |

|---|---|

| Bioavailability | Negligible (Epicutaneous); Moderate (Subcutaneous) |

| Protein Binding | Primarily binds to IgE and IgG antibodies |

| Half-life | Proteins are degraded within hours by proteases |

| Tmax | 15-20 minutes (local tissue concentration) |

| Metabolism | Proteolysis (breakdown into amino acids) |

| Excretion | Renal (as small peptide fragments) |

• Molecular Components: The extract contains a complex mixture of proteins, glycoproteins, and polysaccharides. Key volatile components of the plant include thujone, camphor, and cineole, though these are largely removed or minimized in aqueous clinical extracts.
• Solubility: The extract is soluble in water and is typically stabilized in a solution of 50% glycerin and 0.45% phenol (as a preservative).
• Molecular Weight: Ranges from 10,000 to over 100,000 Daltons for the various allergenic protein fractions.

Sage belongs to the Non-Standardized Plant Allergenic Extract class. It is grouped with other botanical extracts like Ragweed, Oak, and Grass extracts. Unlike 'Standardized' extracts which are measured in Bioequivalent Allergy Units (BAU), Sage is 'Non-Standardized,' meaning its potency is determined by the weight of the raw material per volume of solvent (w/v).